Emmaus Life Sciences, Inc.
General ticker "EMMA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.0M (TTM average)
Emmaus Life Sciences, Inc. does not follow the US Stock Market performance with the rate: -16.4%.
Estimated limits based on current volatility of 0.6%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 55 as of 2022
- Top business risk factors: Economic downturns and volatility, Dependence on endari, Operational and conduct risks, Market competition, Regulatory and compliance
- Current price 81.0% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.04$, 0.16$]
- 2024-12-30 to 2025-12-30 estimated range: [0.05$, 0.18$]
Financial Metrics affecting the EMMA estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 11.96
- Negative: Operating cash flow per share per price, % of -27.54 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -14.38 < Investing cash flow per share per price, % of -7.91
- Negative: Shareholder equity ratio, % of -135.75 <= 18.93
Short-term EMMA quotes
Long-term EMMA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $18.39MM | $29.60MM | $16.65MM |
| Operating Expenses | $24.98MM | $26.06MM | $18.55MM |
| Operating Income | $-6.59MM | $3.54MM | $-1.89MM |
| Non-Operating Income | $-3.98MM | $-7.33MM | $-4.53MM |
| Interest Expense | $5.01MM | $7.38MM | $5.49MM |
| R&D Expense | $1.73MM | $1.19MM | $0.66MM |
| Income(Loss) | $-10.56MM | $-3.79MM | $-6.42MM |
| Taxes | $0.06MM | $-0.06MM | $0.03MM |
| Profit(Loss)* | $-10.62MM | $-3.73MM | $-6.45MM |
| Stockholders Equity | $-34.09MM | $-47.76MM | $-56.48MM |
| Inventory | $2.38MM | $1.71MM | $1.64MM |
| Assets | $48.23MM | $35.18MM | $23.60MM |
| Operating Cash Flow | $-5.07MM | $-1.50MM | $-2.29MM |
| Capital expenditure | $0.03MM | $0.02MM | $0.01MM |
| Investing Cash Flow | $-2.39MM | $-0.43MM | $2.50MM |
| Financing Cash Flow | $7.23MM | $2.48MM | $-1.35MM |
| Earnings Per Share** | $-0.21 | $-0.07 | $-0.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.